Research chemical comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-06-18. Where a claim depends on a specific study, the study is described rather than over-claimed.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA as a PPARδ agonist. |
| Typical detection matrix | Urine | Most common sample for anti-doping analysis. |
| Common analytical method | LC-MS/MS | Liquid chromatography-tandem mass spectrometry. |
| Common synonyms | GW501516, GSK-516, endurobol | Names found in research and fitness contexts. |
| Typical detection window | Variable | Depends on dose, route, and individual metabolism. |
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
== History == Balmer Lawrie was founded as a partnership firm on 1 February 1867 in Calcutta, British India, by two Scotsmen: George Stephen Balmer and Alexander Lawrie. It became a private limited company in 1924 with a paid-up share capital of ₹40 lakhs, a public limited company in 1936 and then a Government of India Enterprise in 1972. BL is classified as a category-I Miniratna company.
Official website – Government of Belize. Archived 10 January 2021 at the Wayback Machine. Official webpage of Queen Elizabeth II (as former Queen of Belize) Wikimedia Atlas of Belize Profile at U.S. Department of State Archived 25 November 2017 at the Wayback Machine Belize National Emergency Management Organization – Official governmental site Belize Wildlife Conservation Network – Belize Wildlife Conservation Network (archived 4 February 2013) CATHALAC – Water Center for the Humid Tropics of Latin America and the Caribbean (archived 5 February 2012) LANIC Belize page Archived 17 December 2024 at the Wayback Machine Belize. The World Factbook. Central Intelligence Agency. Belize at UCB Libraries GovPubs (archived 11 May 2013) Belize from the BBC News Key Development Forecasts for Belize from International Futures Hydromet.gov.bz – Official website of the Belize National Meteorological Service Bileez Kriol Wiki – A wiki in Belizean Creole about Belize
== Products == Renovo does not currently have any marketed products. Its development pipeline currently includes one drug in phase III clinical development, two in phase II clinical development, and numerous pre-clinical candidates.
=== Cyanide poisoning === Since its reduction potential is similar to that of oxygen and can be reduced by components of the electron transport chain, large doses of methylene blue are sometimes used as an antidote for cyanide poisoning, a method first successfully tested in 1933 by Matilda Moldenhauer Brooks in San Francisco, although first demonstrated by Bo Sahlin of Lund University, in 1926.
Aflibercept: A human recombinant protein that aids in the treatment of oxaliplatin-resistant metastatic colorectal cancer, neo-vascular macular degeneration, and macular edema. Rilonacept: Reduces inflammation by preventing activation of IL-1 receptors to treat cryopyrin-associated periodic syndromes (CAPS). Alefacept: Regulated T-cell responses by selectively targeting effector memory T-cells to treat psoriasis vulgaris. Romiplostim: A peptibody that treats immune thrombocytopenia. Abatacept/Belatacept: Interferes with T-cell co-stimulation to treat autoimmune disorders like rheumatoid arthritis, psoriatic arthritis, and psoriasis. Denileukin-diftitox: Treats cutaneous lymphoma.
Sources: en.wikipedia.org
Representative values of this ratio for a few liquids are given in Table 1. The conclusion is that quantum effects are important for liquids at low temperatures and with small molecular mass. For dynamic processes, there is an additional timescale constraint:
According to some officials, Cubans were being removed from their posts in Venezuela's General Directorate of Military Counterintelligence (DGCIM). On 6 January 55 military deaths were confirmed: the victims were 32 Cubans and 23 Venezuelans. Both the countries released on the same day the identities of the killed soldiers. Also on 6 January, military forces posted a video on social media in honor of 24 soldiers killed during the attack. Attorney General Tarek William Saab indicated that dozens of military personnel and civilians were killed and the total number is still under investigation. A day later, Diosdado Cabello said that 100 persons died during the bombing. Independent monitors reported as of 7 January Venezuelan military casualties as of 6 January of 42 or 43 soldiers (mostly at Fort Tiuna), in addition to the 32 Cuban military personnel, and 2 civilians. On 16 January, Venezuelan defense minister Vladimir Padrino López, said that 47 soldiers, including 9 women, were killed during the attack. Acting president Delcy Rodríguez declared seven days of mourning for the soldiers killed during the attack. The remains of the Cuban fatalities were repatriated on 15 January. They received a mass funeral ceremony in Havana upon arrival. In Catia La Mar, strikes hit a three-story civilian apartment complex, killing one person, seriously injuring another, and destroying the exterior wall. Yohana Rodríguez Sierra, a Colombian citizen, was reported as a civilian fatality in El Hatillo.
== History == One of the first scientific reports is the colloidal gold particles synthesized by Michael Faraday as early as 1857. By the early 1940's, precipitated and fumed silica nanoparticles were being manufactured and sold in USA and Germany as substitutes for ultrafine carbon black for rubber reinforcements.
== Contraindications == Etifoxine is contraindicated in people with circulatory shock, severe liver impairment, severe kidney impairment, myasthenia gravis, galactosemia (due to lactose in the drug formulation), severe respiratory failure, and hypersensitivity (allergy) to etifoxine. The medication is not recommended in children or adolescents under the age of 18 and is not recommended during pregnancy and breastfeeding due to insufficient data. Caution is warranted with regard to combining etifoxine and other central depressants such as benzodiazepines, central analgesics, antipsychotics, sedative antihistamines, and alcohol.
S = Salt factor F = Bioavailability D = Dose ke = Elimination rate constant ka = Absorption rate constant Vd = Volume of distribution τ = Dosing interval Cmin is also an important parameter in bioavailability and bioequivalence studies, it is part of the pharmacokinetic information recommended for submission of investigational new drug applications.
Sources: en.wikipedia.org
Yes, WADA prohibits cardarine as a PPARδ agonist. It appears on the prohibited list and can be detected in urine or blood. Athletes using it risk sanctions.
Detection usually uses liquid chromatography-tandem mass spectrometry after sample cleanup. Laboratories look for the parent compound or metabolites. The method requires validated reference standards and controls.
Legality varies by country. In many places it is an unapproved drug and cannot be legally sold for human consumption. Purchasing from online vendors carries legal and quality risks.
Cardarine is commonly known as GW501516 or GW-1516. These names refer to the same synthetic compound. It is not a brand-name approved medicine.